Edit Module

Virbac Unveils Canine Cephalexin Tablet

Posted: Sept. 5, 2012, 8:05 p.m. EDT


Virbac Animal Health of Fort Worth, Texas, launched the first chewable cephalexin tablet designed exclusively for dogs, the company reported Tuesday.

The FDA-approved drug, called Rilexine, is indicated for the treatment of secondary superficial bacterial pyoderma in dogs caused by susceptible strains of Staphylococcus pseudintermedius.

Previously, veterinarians often relied on the generic human form of cephalexin to treat dogs, but Rilexine is the first drug of its kind approved by the U.S. Food and Drug administration for the veterinary market, Virbac reported. The new drug should overcome some of the drawbacks of prescribing human cephalexin off-label, including a bitter, metallic taste and strong odor, a lack of veterinary-specific guidelines and the inability to tailor doses, Virbac noted.

Pyoderma is one of the most common diseases seen in dogs, and secondary superficial bacterial pyoderma is the most common form of pyoderma, according to Virbac.

Rilexine is available in 150 mg, 300 mg and 600 mg scored doses. The drug should not be prescribed to dogs that have a known allergy to cephalexin or the B-lactam group of antibiotics.


Edit Module
Edit ModuleShow Tags

Archive »Read More

New Treatment Could Prevent Uterine Disease in Cows

University of Florida researchers say that a new biological treatment could prevent dairy cattle from getting uterine diseases.

Michigan Revamps Vet Curriculum with Hopes to Reduce Student Debt

In an effort to reduce student debt, Michigan State University’s College of Veterinary Medicine plans to implement a new curriculum by fall semester 2018.

Cat-Killing Vet Has License Suspended

The lawyer for Kristen Lindsey, DVM, the veterinarian who killed a cat with a bow-and-arrow, vowed to appeal the decision.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags


Show More...
Edit Module
Edit Module